Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:


Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?

ZYDUS PHARMS USA has fifty-seven approved drugs.

There are twenty-one tentative approvals on ZYDUS PHARMS USA drugs.

Summary for Zydus Pharms Usa
US Patents:0

Drugs and US Patents for Zydus Pharms Usa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa LAMOTRIGINE lamotrigine TABLET;ORAL 077633-002 Jan 27, 2009 RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 078920-001 Jul 6, 2010 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa SIMVASTATIN simvastatin TABLET;ORAL 077837-004 Dec 20, 2006 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 077100-002 Mar 5, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-003 Jan 28, 2008 AB RX No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.